Why BioNTech Stock Jumped Today
Shares of BioNTech (NASDAQ: BNTX) climbed on Friday after the biotechnology company and its pharmaceutical partner Pfizer (NYSE: PFE) released positive data related to their COVID-19 vaccine candidate. As of 3:40 p.m. EDT, BioNTech's stock was up 10% after rising as much as 15% earlier in the day.
BioNTech and Pfizer's coronavirus vaccine candidate, BNT162b2, showed a strong ability to provoke an immune response in both young and older adults. It was also generally well tolerated; fewer than 20% of the study's participants experienced mild to moderate fever, and only a small number suffered more severe events, such as muscle and joint pain, which were temporary and manageable.
BioNTech's stock rose sharply on Friday. Image source: Getty Images.
Source Fool.com
